These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11143542)

  • 1. [Therapy of onychomycosis].
    Reisberger EM; Szeimies RM
    Med Klin (Munich); 2000 Nov; 95(11):618-28. PubMed ID: 11143542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis.
    Gupta AK
    J Am Podiatr Med Assoc; 2002 May; 92(5):272-86. PubMed ID: 12015408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onychomycosis in children: a brief overview with treatment strategies.
    Gupta AK; Skinner AR
    Pediatr Dermatol; 2004; 21(1):74-9. PubMed ID: 14871333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal therapy for onychomycosis in children.
    Feldstein S; Totri C; Friedlander SF
    Clin Dermatol; 2015; 33(3):333-9. PubMed ID: 25889135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral therapeutic agents in fungal nail disease.
    Roberts DT
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S78-81. PubMed ID: 8077514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of toenail onychomycosis.
    Tom CM; Kane MP
    Am J Health Syst Pharm; 1999 May; 56(9):865-71. PubMed ID: 10344609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.
    Gupta AK; Shear NH
    Drug Saf; 2000 Jan; 22(1):33-52. PubMed ID: 10647975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
    Schaller M; Sigurgeirsson B; Sarkany M
    Mycoses; 2017 Dec; 60(12):800-807. PubMed ID: 28925059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of onychomycoses.
    Niewerth M; Korting HC
    Drugs; 1999 Aug; 58(2):283-96. PubMed ID: 10473020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
    Avner S; Nir N; Henri T
    J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terbinafine: a review of its use in onychomycosis in adults.
    Darkes MJ; Scott LJ; Goa KL
    Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onychomycosis in the elderly.
    Gupta AK
    Drugs Aging; 2000 Jun; 16(6):397-407. PubMed ID: 10939306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A questionnaire study on the management of onychomycosis: a Canadian perspective.
    Gupta AK; Shear NH
    Int J Dermatol; 1998 Jun; 37(6):457-60. PubMed ID: 9646138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of onychomycosis: a randomized, double-blind comparison study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin.
    Friedman-Birnbaum R; Cohen A; Shemer A; Bitterman O; Bergman R; Stettendorf S
    Int J Dermatol; 1997 Jan; 36(1):67-9. PubMed ID: 9071624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis.
    Del Rosso JQ
    J Am Osteopath Assoc; 1997 Jun; 97(6):339-46. PubMed ID: 9232944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciclopirox nail lacquer: a brush with onychomycosis.
    Gupta AK
    Cutis; 2001 Aug; 68(2 Suppl):13-6. PubMed ID: 11665723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis, differential diagnosis and therapy of onychomycosis].
    Seebacher C
    Z Arztl Fortbild Qualitatssich; 1998 Apr; 92(3):187-90. PubMed ID: 9606886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.